FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089114 [Registered on: 19/06/2025] Trial Registered Prospectively
Last Modified On: 18/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A comparative study of efficacy of ambashtha-kshiriwalkal taila yoni pichu and jatyadi taila yoni pichu on cervical erosion (garbhashayamukh vrana) 
Scientific Title of Study   A Randomized controlled clinical trial to compare the efficacy of ambashtha-kshiriwalkal taila yoni pichu and jatyadi taila yoni pichu on cervical erosion (garbhashayamukh vrana)  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Priyanka Dilip Bendre 
Designation  PG Scholar  
Affiliation  Tilak Ayurved Mahavidyalaya,Rasta Peth,Pune,Maharashtra 
Address  Tilak Ayurved Mahavidyalaya,Department of Stree-rog and prasuti tantra,Rasta Peth,Pune seth Tarachand Ramnath Ayurvedic Hospital,rasta Peth, Pune,Maharashtra

Pune
MAHARASHTRA
411011
India 
Phone  9209716208  
Fax    
Email  drbendrepriya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Rucha Ganu 
Designation  Head of the Department, Department of Stree-Rog and Prasutitantra 
Affiliation  Tilak Ayurved Mahavidyalaya,Rasta Peth,Pune,Maharashtra 
Address  Tilak Ayurved Mahavidyalaya,Department of Stree-rog and prasuti tantra,Rasta Peth,Pune seth Tarachand Ramnath Ayurvedic Hospital,rasta Peth, Pune,Maharashtra

Pune
MAHARASHTRA
411011
India 
Phone  9822376936  
Fax    
Email  ganu.rucha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vd Priyanka Dilip Bendre 
Designation  PG Scholar  
Affiliation  Tilak Ayurved Mahavidyalaya,Rasta Peth,Pune,Maharashtra 
Address  Tilak Ayurved Mahavidyalaya,Department of Stree-rog and prasuti tantra,Rasta Peth,Pune seth Tarachand Ramnath Ayurvedic Hospital,rasta Peth, Pune,Maharashtra

Pune
MAHARASHTRA
411011
India 
Phone  9209716208  
Fax    
Email  drbendrepriya@gmail.com  
 
Source of Monetary or Material Support  
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital,Rasta Peth,Pune 411011 
 
Primary Sponsor  
Name  Tilak Ayurved Mahavidyalaya,Pune 
Address  Rasta Peth,Pune,411011 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPriyanka Dilip Bendre  Seth Tarachand Ramnath Charitable Ayurvedic Hospital  Department of stree-Rog and Prasutitantra,Ground floor,OPD No.11
Pune
MAHARASHTRA 
09209716208

drbendrepriya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,TAMV Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N86||Erosion and ectropion of cervix uteri. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Jatyadi taila, Reference: Bhaishajya Ratnawali , Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: Medicine will be used by the procedure of yoni pichu
2Intervention ArmDrugClassical(1) Medicine Name: Ambashtha Kshiriwalkal, Reference: Chikitsa arnav, Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: Medicine will be used by the procedure of yoni pichu
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Married female between 25-40 years age group
2.Participant clinically diagnosed with cervical erosion 
 
ExclusionCriteria 
Details  1.Presence of active infection in the genital tract
2.Any growth in genital tract
3.ANC and PNC patient
4.Anaemic patients (Hb less than 8 mg/dl)
5.Serologically positive patient of HIV, HbsAg
6.Patient with sexually transmitted disease  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the efficacy of Ambashtha-Kshiriwalkal taila yoni pichu on cervical erosion (Garbhashay mukh vrana)in comparison with jatyadi taila yoni pichu  7 days for 3 consecutive menstrual cycles  
 
Secondary Outcome  
Outcome  TimePoints 
Decrease in symptoms of vaginal discharge  7 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will be intervened by the treatment of Ambashtha Kshiriwalkal Taila yoni pichu and Jatyadi Taila yoni pichu to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for stastical analysis. Scoring will be designed according to the severity of symptoms. The subjective gradation of symptoms will be done as follows and intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regard to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method. 
Close